Los Angeles Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $120K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $175K | Sell |
|
|||||
|
2022
Q3 | $422K | Buy |
|
|||||
|
2022
Q2 | $436K | Buy |
|
|||||
|
2022
Q1 | $658K | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Hold |
|
|||||
|
2021
Q2 | $1.53M | Sell |
|
|||||
|
2021
Q1 | $1.6M | Sell |
|
|||||
|
2020
Q4 | $2.8M | Buy |
|
|||||
|
2020
Q3 | $1.22M | Buy |
|
|||||
|
2020
Q2 | $998K | Buy |
|
|||||
|
2020
Q1 | $566K | Buy |
|